Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
Obscurolide A1
As low as
CHF 145.00
In stock
Only %1 left
BVT-0287-M0011 mgCHF 145.00
Specifications / Handling
| Product Details | |
|---|---|
| Synonyms | (E)-4-((2-(3-Hydroxybut-1-en-1-yl)-5-oxotetra-hydrofuran-3-yl)amino)benzoic acid |
| Product Type | Chemical |
| Properties | |
| Formula |
C15H17NO5 |
| MW | 291.3 |
| CAS | 144397-99-9 |
| Source/Host Chemicals | Isolated from Streptomyces viridochromogenes. |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | Off-white to pale yellow powder. |
| Solubility | Soluble in methanol, DMSO or acetone. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by BioViotica. |
| InChi Key | IZSWILLJDXDGDJ-FARCUNLSSA-N |
| Smiles | CC(O)\C=C\C1OC(=O)CC1NC1=CC=C(C=C1)C(O)=O |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C. |
| Documents | |
| Safety Data Sheet |
Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Scientific Background Information
Product Description
- Weak phosphodiesterase inhibitor.
Product-specific References
- Metabolic products of microorganisms. 261. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. I. Production, isolation, structural elucidation and biological activity of obscurolides A1 to A4: H. Hoff, et al.; J. Antibiot. 45, 1096 (1992)
You're in the Switzerland store. Not in Switzerland? Choose your country
You're in the Switzerland store (prices in CHF, shipping to Switzerland only). Ordering from another country? Please select it below.
Please note that not all products are available in every country store. Choose your country before starting the ordering process.
Country
Switzerland
United Kingdom
France
Germany
Austria
Italy
South Korea
United States
Argentina
Australia
Belgium
Bosnia and Herzegovina
Brazil
Canada
Chile
China
Colombia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
Greece
Hong Kong
Hungary
India
Iran
Iraq
Ireland
Israel
Japan
Latvia
Lithuania
Luxembourg
Malaysia
Mexico
Netherlands
New Zealand
Norway
Pakistan
Peru
Poland
Portugal
Romania
Russia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Syria
Taiwan
Thailand
Turkey
Uruguay
Venezuela
Other Country
No country found




Download PDF


